Renata
Renata launches medicine for hyperprolactinemia and Parkinson’s disease in Australia
The drug is manufactured at Renata's factory in Mirpur
Renata’s profit rises 55% to Tk 362 crore
The company announced a cash dividend of 92%, up from the previous year’s 62.5%
Renata to sign deal with IFC for $60 million loan
The fund will be given as working capital
Renata starts directly exporting medicines to US
Renata PLC has begun exporting medicines to the US market, becoming the sixth pharmaceutical manufacturer from Bangladesh to directly ship products to the world's largest market
Renata gets nod to raise Tk 350 crore
Shares of the listed drug maker dropped 1.17 percent yesterday from that on the day before to Tk 877
Renata launches medicine for hyperprolactinemia and Parkinson’s disease in Australia
The drug is manufactured at Renata's factory in Mirpur
Renata’s profit rises 55% to Tk 362 crore
The company announced a cash dividend of 92%, up from the previous year’s 62.5%
Renata to sign deal with IFC for $60 million loan
The fund will be given as working capital
Renata starts directly exporting medicines to US
Renata PLC has begun exporting medicines to the US market, becoming the sixth pharmaceutical manufacturer from Bangladesh to directly ship products to the world's largest market
Renata gets nod to raise Tk 350 crore
Shares of the listed drug maker dropped 1.17 percent yesterday from that on the day before to Tk 877